|Articles|February 19, 2016

Pharm Exec AAM 062015

External Link - PE_AAM_June2015.pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe

Related Content

Pharmaceutical Executive Daily: Novo Nordisk Files Lawsuit Against Eli Lilly

ByNicholas Jacobus

July 22nd 2026

President Trump Announces Phased Generic Drug Tariff Plan: Report

ByNicholas Jacobus

Published: July 22nd 2026 | Updated: July 22nd 2026

How Realistic Project TrialBlazer’s Stated Goals Are

ByMike Hollan,Dr. Richard Graham

July 22nd 2026

Gerren McHam, vice president of Government and External Affairs, API Innovation Center,

How Has The Strait of Hormuz Situation Shaped The API Innovation Center's Thinking About Geographic Diversification?

ByNicholas Jacobus,Gerren McHam

July 22nd 2026

The Remaining Gaps in Employer-Covered GLP-1 Benefits

ByMike Hollan,Susan Thomas

July 22nd 2026

Pharm Exec AAM 062015

Related Content

Pharmaceutical Executive Daily: Novo Nordisk Files Lawsuit Against Eli Lilly

President Trump Announces Phased Generic Drug Tariff Plan: Report

How Realistic Project TrialBlazer’s Stated Goals Are

How Has The Strait of Hormuz Situation Shaped The API Innovation Center's Thinking About Geographic Diversification?

The Remaining Gaps in Employer-Covered GLP-1 Benefits

Trending on PharmExec

President Trump Announces Phased Generic Drug Tariff Plan: Report

The Remaining Gaps in Employer-Covered GLP-1 Benefits

How Realistic Project TrialBlazer’s Stated Goals Are

R&D Is Investing in AI, Just Not Where It Matters Most

How Has The Strait of Hormuz Situation Shaped The API Innovation Center's Thinking About Geographic Diversification?